| Document Date: 2012-07-17 12:33:16
Open Document File Size: 211,02 KBShare Result on Facebook
City Vienna / / Company Sanofi / Glaxosmithkline plc / / Country Austria / / / Event FDA Phase / / Facility Pediatric Dengue Vaccine Initiative International Vaccine Institute / / MedicalCondition ?infection / disease / Infectious clones / immune enhanced disease / yellow fever / dengue / infection / Hawaii Biotech Hawaii Biotech Q12009 Chimeric Flavivirus Vaccine Technology Yellow fever 17D / Type-specific dengue virus / dengue viruses / / MedicalTreatment immunization / immunization schedule / / Organization National Institute of Health / Pediatric Dengue Vaccine Initiative International Vaccine Institute Seoul / / Person Pediatric Dengue / Pediatric Dengue Vaccine / Approach Acambis / Harold S. Margolis / / Position WRAIR Producer / Producer / Director / / Product Dengue Vaccine / / Technology DNA shuffling / 2009 Hawaii Biotech Hawaii Biotech Q12009 Chimeric Flavivirus Vaccine Technology / directed mutagenesis / /
SocialTag |
Dengue Vaccine Development Harold S. Margolis, MD Director, Pediatric Dengue Vaccine Initiative International Vaccine Institute Seoul, Korea [removed]